Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the […]
Siebert Financial Corp. Announces the Launch of ‘Siebert.Valor’ in Honor of Service Members’ Financial Empowerment
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB), a pioneer in the financial services industry, […]
CompoSecure Earns Global Recognition in 2024 with 9 Awards and 11 Finalist Honors
SOMERSET, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and […]
Alliance Entertainment Acquires Handmade by Robots
PLANTATION, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a global distributor and wholesaler specializing […]
Rezolve Ai Announces $49 Million Equity Conversion by Leading Investors
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail innovation, and […]
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
– Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer – […]
Saratoga Investment Corp. to Report Fiscal Third Quarter 2025 Financial Results and Hold Conference Call
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial […]
KULR Regains Compliance with NYSE American Stockholders’ Equity Requirement
HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leader […]
Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model
FREEHOLD, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) — Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer […]
CleanCore Solutions, Inc. (ZONE) Applauds EPA’s Recent Ban of Two Cancer-Causing Chemicals
Omaha, NE, Dec. 18, 2024 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of […]
